Chemed

Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.

Earnings data Q2 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Investors continue to be optimistic about Chemed (CHE) on the strong performance of the VITAS Healthcare and Roto-Rooter segments.

Here's Why You Should Retain Chemed (CHE) Stock for Now

Darling Ingredients

Tenet Healthcare

Viking Therapeutics

Lantheus Holdings

Merus

Carrols Restaurant Group

Stock screeners can help investors identify stocks to buy based on a variety of criteria. In fact, one helpful predictor of stock price growth can be found with analyst ratings.

7 Stocks That Wall Street Analysts Are Loving in May

Chemed remains an attractive buy with exceptional business economics to create future value. Bottom-line fundamentals look resilient despite macro-volatility, and labor issues are now sorted.

Chemed: Adding Value At Double Digits Above Its Hurdle Rate

UiPath

CINCINNATI--(BUSINESS WIRE)--Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company's 2023 annual stockholders' meeting. New to the Board is Eileen McCarthy, Senior Vice President of UiPath, Inc. (NYSE: PATH). Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2023. Stockholders also approved Chemed's executive compensation and recommended the say-on-pay vote remain an annual vote. In addi.

Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend

Chemtrade Logistics Income Fund (OTC:CGIFF) Q1 2023 Earnings Conference Call May 11, 2023 8:30 AM ET Company Participants Scott Rook - President and Chief Executive Officer Rohit Bhardwaj - Chief Financial Officer Conference Call Participants Gary Ho - Desjardins Ben Isaacson - Scotiabank Steve Hansen - Raymond James Endri Leno - National Bank Financial Operator Good morning ladies and gentlemen and welcome to the Chemtrade Logistics Income Fund First Quarter 2023 Earnings Call. [Operator Instructions] This call is being recorded on Thursday, May 11, 2023.

Chemtrade Logistics Income Fund (CGIFF) Q1 2023 Earnings Call Transcript

DaVita

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with DaVita HealthCare (DVA) and Chemed (CHE). But which of these two companies is the best option for those looking for undervalued stocks?

DVA vs. CHE: Which Stock Should Value Investors Buy Now?

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 17, 2023, at approximately 2:35 p.m. (ET) at The InterContinental New York Barclay Hotel in New York City. The audio webcast can be accessed by visiting the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours after the live presentation and will be accessibl.

Chemed Corporation to Present at the 2023 RBC Global Healthcare Conference

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Merrill Lynch 2023 Health Care Conference on Wednesday, May 10, 2023, at 10:40 AM (PDT) at the Encore at the Wynn Las Vegas. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentati.

Chemed Corporation to Present at the Bank of America Merrill Lynch 2023 Health Care Conference

Chemed Corporation (NYSE:CHE ) Q1 2023 Earnings Conference Call April 27, 2023 10:00 AM ET Company Participants Holley Schmidt - Assistant Controller Kevin McNamara - President and Chief Executive Officer David Williams - Executive Vice President and Chief Financial Officer Nicholas Westfall - President and Chief Executive Officer-VITAS Healthcare Corporation Subsidiary Conference Call Participants Joanna Gajuk - Bank of America Benjamin Hendrix - RBC Capital Markets Operator Thank you for standing by, and welcome to the Chemed First Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder today's call is being recorded.

Chemed Corporation (CHE) Q1 2023 Earnings Call Transcript

Strength in the VITAS and Roto-Rooter branches contributes to Chemed's (CHE) first-quarter top line.

Chemed (CHE) Lags Q1 Earnings Estimates, Reaffirms Guidance

Chemed (CHE) came out with quarterly earnings of $4.82 per share, missing the Zacks Consensus Estimate of $4.92 per share. This compares to earnings of $4.79 per share a year ago.

Chemed (CHE) Q1 Earnings Lag Estimates

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2023, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 5.6% to $560 million GAAP Dilut.

Chemed Reports First-Quarter 2023 Results

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2023, on Wednesday, April 26, 2023, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, April 27, 2023, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through.

Chemed To Report First-Quarter 2023 Earnings April 26, Related Conference Call To Be Held On April 27

Encompass Health

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Encompass Health (EHC) and Chemed (CHE). But which of these two companies is the best option for those looking for undervalued stocks?

EHC vs. CHE: Which Stock Is the Better Value Option?

Pennant Group Inc

PNTG vs. CHE: Which Stock Is the Better Value Option?

PNTG vs. CHE: Which Stock Should Value Investors Buy Now?

Addus HomeCare

RadNet

Despite the macroeconomic challenges, rising dependence on telehealth and the dominance of AI are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. CHE, ADUS, RDNT and PNTG are well poised to gain from the prospects.

4 Promising Stocks From a Challenging Outpatient Home Health Industry

Chemed (CHE) records increases in drain cleaning, plumbing, excavation and water restoration revenues within the Roto-Rooter branch commercial business.

Chemed (CHE) Up on Roto-Rooter Sales Growth, Strong Admissions

PNTG or CHE: Which Is the Better Value Stock Right Now?

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 33rd Annual Healthcare Conference on Tuesday, March 14, 2023, at approximately 1:20 p.m. (ET). The virtual presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations).

Chemed Corporation to Present at the Oppenheimer 33rd Annual Healthcare Conference

Chemtrade Logistics Income Fund (OTC:CGIFF) Q4 2022 Earnings Conference Call February 23, 2023 10:00 AM ET Company Participants Rohit Bhardwaj - Chief Financial Officer Scott Rook - President & Chief Executive Officer Conference Call Participants Jacob Bout - CIBC Joel Jackson - BMO Capital Markets Steve Hansen - Raymond James Gary Ho - Desjardins Nelson Ng - RBC Capital Markets Operator Good morning, ladies and gentlemen, and welcome to the Chemtrade Logistics Income Fund Q4 2022 Annual Results Conference Call. At this time, all lines are in a listen-only mode.

Chemtrade Logistics Income Fund (CGIFF) Q4 2022 Earnings Call Transcript

Chemed Corporation (NYSE:CHE ) Q4 2022 Earnings Conference Call February 24, 2023 10:00 AM ET Company Participants Holley Schmidt – Assistant Controller Kevin McNamara – President and Chief Executive Officer Dave Williams – Executive Vice President and Chief Financial Officer Nick Westfall – President and Chief Executive Officer-VITAS Healthcare Corporation Subsidiary Conference Call Participants Joanna Gajuk – Bank of America Ben Hendrix – RBC Capital Markets Mike Wiederhorn – Oppenheimer Holley Schmidt Good morning. Our conference call this morning will review the financial results for the Fourth Quarter of 2022 ended December 31, 2022.

Chemed Corporation (CHE) Q4 2022 Earnings Call Transcript

Chemed (CHE) reports impressive sales growth in the Roto-Rooter subsidiary in the fourth quarter of 2022.

Chemed (CHE) Q4 Earnings Beat Estimates, Margins Contract

Chemed (CHE) delivered earnings and revenue surprises of 1.70% and 0.63%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Chemed (CHE) Tops Q4 Earnings and Revenue Estimates

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2022, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 1.

News for Chemed Stock (CHE)